Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

27.79 +0.28 (+1.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,999,507
Open 26.12
Bid (Size) 27.00 (200)
Ask (Size) 27.79 (1,000)
Prev. Close 27.51
Today's Range 25.62 - 28.39
52wk Range 5.500 - 71.50
Shares Outstanding 54,865,673
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
A Glimpse of uniQure's Earnings Potential
 
Via Benzinga

Performance

YTD
+54.0%
+54.0%
1 Month
-53.7%
-53.7%
3 Month
+109.3%
+109.3%
6 Month
+117.3%
+117.3%
1 Year
+274.0%
+274.0%

More News

Read More
uniQure to Announce Third Quarter 2025 Financial Results
From uniQure Inc.
Via GlobeNewswire
uniQure Stock Tumbled 56% Today: What’s The FDA Angle?
Via Stocktwits
Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection
Via Benzinga
UNIQURE ALERT: Bragar Eagel & Squire, P.C. is Investigating uniQure N.V. on Behalf of uniQure Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Biohaven Craters After FDA Unexpectedly Rejects Its High-Profile Drug
Via Investor's Business Daily
Topics Earnings
Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
uniQure N.V. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (QURE)
From Kirby McInerney LLP
Via GlobeNewswire
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
Via Benzinga
NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
Which stocks are moving on Monday?
Via Chartmill
Gold Edges Higher; ISM Manufacturing PMI Falls In October
Via Benzinga
UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data
Via Benzinga
Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session.
Via Chartmill
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Gapping stocks in Monday's session
Via Chartmill
uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE
From The DJS Law Group
Via Business Wire

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?
Yes, uniQure N.V. - Ordinary Shares is publicly traded.
What exchange does uniQure N.V. - Ordinary Shares trade on?
uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for uniQure N.V. - Ordinary Shares?
The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market
What is the current price of uniQure N.V. - Ordinary Shares?
The current price of uniQure N.V. - Ordinary Shares is 27.79
When was uniQure N.V. - Ordinary Shares last traded?
The last trade of uniQure N.V. - Ordinary Shares was at 11/07/25 04:00 PM ET
What is the market capitalization of uniQure N.V. - Ordinary Shares?
The market capitalization of uniQure N.V. - Ordinary Shares is 1.52B
How many shares of uniQure N.V. - Ordinary Shares are outstanding?
uniQure N.V. - Ordinary Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.